Julia Gregory
Chairman at NURIX THERAPEUTICS, INC.
Net worth: 989 129 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Cargill | M | 40 | 7 years | |
| Gregory Bailey | M | 68 | 10 years | |
| Vladimir Coric | M | 53 | 9 years | |
| George Clark | M | - | 5 years | |
| Irina Antonijevic | M | 59 | 2 years | |
| Michael Heffernan | M | 59 | 4 years | |
| John Childs | M | 81 | 10 years | |
| Robert Hugin | M | 69 | 4 years | |
| Arthur Sands | M | 62 | 10 years | |
| Michiel C. McCarty | M | 72 |
M.M. Dillon & Co. LLC
 M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT.
Dillon, Read & Co., Inc.
| 28 years |
| Kishan Mehta | M | 38 | 3 years | |
| Douglas G. Gray | M | - | - | |
| Christine Ring | M | 59 | 5 years | |
| Samuel Barker | M | 81 | 24 years | |
| Kirk Dornbush | M | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 21 years |
| Amit Chunilal Nathwani | M | 64 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Kimberly Gentile | F | 56 | 9 years | |
| Clifford Bechtold | M | - | 7 years | |
| Michael P. Bailey | M | 58 | 4 years | |
| Andrew Hall | M | - | 4 years | |
| Matthew Buten | M | 62 | 3 years | |
| Jason Daniel Kantor | M | - | 4 years | |
| Ray Debbane | M | 69 | 17 years | |
| Saman Maleki | M | - | 2 years | |
| Jennifer Porcelli | F | - | 2 years | |
| Delphine Davan | F | - | 5 years | |
| Irfan Qureshi | M | - | - | |
| Paloma Moraleda | F | - | 2 years | |
| Michael Kalos | M | 62 | 3 years | |
| David Saunders | M | - | 4 years | |
| Megan M. Dow | M | - | 4 years | |
| Edward Saltzman | M | 69 | 2 years | |
| Markus Warmuth | M | 53 | 6 years | |
| David Roblin | M | 57 | 6 years | |
| Philippe Amouyal | M | 65 | 17 years | |
| Judith Reinsdorf | F | 60 | 3 years | |
| George Bickerstaff | M | 68 |
M.M. Dillon & Co. LLC
M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT. | 19 years |
| Paul Silva | M | 58 | 3 years | |
| Robert Lefkowitz | M | 80 | 23 years | |
| William Greene | M | - |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 years |
| Christopher Sobecki | M | 65 | 17 years | |
| Brian Crum | M | 51 | 23 years | |
| Gastón Ortega | M | - | 2 years | |
| Kuniaki Kaga | M | 72 | 6 years | |
| Judith Swain | M | 75 | 17 years | |
| Kyle Kuvalanka | M | 56 | 3 years | |
| Chris Hollowood | M | 50 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 years |
| Noriaki Nagai | M | 66 | 5 years | |
| Lori Kunkel | M | 66 | 5 years | |
| Shabnam Kazmi | F | - | 1 years | |
| Lisa Stocking | F | - | - | |
| Chris Barrett | M | - | - | |
| Jeffrey Chodakewitz | M | 68 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Todd Foley | M | 52 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 years |
| Warren Volles | M | - | - | |
| K. Hirth | M | 72 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 9 years |
| Jon Blaskovich | M | - | - | |
| Jeremy Graff | M | - | 3 years | |
| Maryellen McQuade | F | - | - | |
| Bruce A. Cohen | M | 71 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | - |
| Gwenn Hansen | M | 53 | 9 years | |
| Colin Love | M | 65 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Melissa Beiner | M | - | - | |
| Caroline Dircks | M | - | 4 years | |
| Martin Andrews | M | 61 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Shuai Li | M | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Messinger | M | 49 | 22 years | |
| Aron M. Knickerbocker | M | 54 | 10 years | |
| Timothy Kutzkey | M | 49 | 10 years | |
| Declan Doogan | M | 72 | 14 years | |
| Steven Gilman | M | 71 | 8 years | |
| Roger Pomerantz | M | 67 | 9 years | |
| Robert Nowinski | M | - | 5 years | |
| Albert Scardino | M | 76 | 10 years | |
| David Lacey | M | 71 | 8 years | |
| Frederic Ors | M | 50 | 6 years | |
| Francis Sarena | M | 53 | 11 years | |
| Peter Bains | M | 65 | 8 years | |
| Gregg Stephen Sando | M | - |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 12 years |
| Elyse Stock | M | 66 | 5 years | |
| David Low | M | 65 | 9 years | |
| Sheng Da Zan | M | 61 | - | |
| Anthony Price | M | - | 8 years | |
| Kenny S. Frazier | M | - | - | |
| Barry Kappel | M | 48 | 6 years | |
| Marc Jasmin | M | - | - | |
| John P. Birkelund | M | 94 |
Dillon, Read & Co., Inc.
| 16 years |
| Robert Tjian | M | 74 | 4 years | |
| Frank Palantoni | M | 66 | 19 years | |
| Takuya Fujii | M | 78 | 12 years | |
| Wayne Pisano | M | 69 | 10 years | |
| Alfred A. Smithers | M | - | 4 years | |
| Jeffrey Tong | M | 48 | 4 years | |
| Eric Aguiar | M | 62 | 4 years | |
| Alan Nies | M | 86 | 20 years | |
| Alan Main | M | 69 | - | |
| Peder Jensen | M | 69 | 10 years | |
| David Scheinberg | M | 68 | 6 years | |
| Steven Alan Tragash | M | 77 | 3 years | |
| James F. Tessmer | M | 64 | 20 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 45.00% |
| Canada | 14 | 14.00% |
| Japan | 7 | 7.00% |
| United Kingdom | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Julia Gregory
- Personal Network
